MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (NASDAQ:OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that Brian Levy, O.D., M.Sc., has joined Ocata’s Board of Directors. Most recently, Dr. Levy served as Chief Medical Officer of Aerie Pharmaceuticals, Inc.
Help employers find you! Check out all the jobs and post your resume.
